Information about clinical trials for rolapitant IV

CLINICAL TRIALS

Rolapitant IV is an investigational product in development for the prevention of delayed chemotherapy-induced nausea and vomiting, or CINV. There are no currently ongoing clinical trials of rolapitant IV. It has not been approved by the FDA or any other regulatory authorities. For more information on rolapitant IV clinical trials, please contact clinicaltrials@tesarobio.com.